The global Human Embryonic Stem Cells (HESC) market is expected to grow at a moderate rate during the forecast period. Growing incidences of genetic disorders is boosting the growth of the global Human Embryonic Stem Cells (HESC) market. An increasing number of research projects for the development of human embryonic stem cells to expand the growth of the market.
Moreover, governments in many countries are supporting and taking initiatives for the research in human embryonic stem cell development in the healthcare sector is the important factor expected to boost the growth of the Human Embryonic Stem Cells (HESC) market in near future. In addition to this, growing health care expenditure is further driving the expansion of this market globally.
On the other hand, a lack of awareness among patients and the high cost of the research along with the challenges associated with the handling and use of human embryonic stem cells is likely to hamper the global Human Embryonic Stem Cells (HESC) market during the forecast period.
Covid-19 Impact on Human Embryonic Stem Cells (HESC) Market:
In addition, the current Human Embryonic Stem Cells (HESC) Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Human Embryonic Stem Cells (HESC) Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Human Embryonic Stem Cells (HESC) Market Segment Overview
According to Type, the market is segmented into Totipotent Stem Cell, Pluripotent Stem Cell, and Unipotent Stem Cell. Among these Totipotent Stem Cell holds the largest share of the market mainly because of the growing research and development of the applications of human embryonic stem cells for bringing up multicellular organisms. This growth in R&D would propel the growth of the segment during the forecast period.
Based on application, the market is segmented into Regenerative medicine, Stem cell biology research, Tissue engineering, and Toxicology testing. In addition, the Regenerative medicine segment are expected to grow at the highest rate in the coming years. This owes to the advantages posed by the segment which includes, promoting the repair response of diseased, dysfunctional or injured tissue using stem cells thus it boosting the demand for Human Embryonic Stem Cells (HESC) globally.
Market Analysis, Insights and Forecast – By Type
· Totipotent Stem Cell
· Pluripotent Stem Cell
· Unipotent Stem Cell
Market Analysis, Insights and Forecast – By Application
· Regenerative medicine
· Stem cell biology research
· Tissue engineering
· Toxicology testing
Human Embryonic Stem Cells (HESC) Market Regional Overview
Region-wise, North America dominated the global Human Embryonic Stem Cells (HESC) market and is expected to continue its dominance during the forecast period. Factors such as the presence of numerous prominent entities incorporated in the U.S., and high health care expenditure propels the growth of the market in North America. Similarly, Asia Pacific is also expected to account for the fastest growth in the global market owing to well-established health care infrastructure. Factors such as development in the health care infrastructure, rising awareness about health, a surge in investment in pharmaceuticals and biotechnology sectors, and growing adoption of human embryonic stem cells are expected to escalate the growth of the Human Embryonic Stem Cells (HESC) market in the Asia Pacific region.
Human Embryonic Stem Cells (HESC) Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Human Embryonic Stem Cells (HESC) Market Competitor overview
Some key developments and strategies adopted by manufacturers in the Human Embryonic Stem Cells (HESC) are highlighted below.
· Invitrogen, and Novocell had announced the launch of a new fully-defined, serum- and feeder-free media specifically formulated for the growth and expansion of human embryonic stem cells (hESCs). The product, known as STEMPRO hESC SFM, will be sold by Invitrogen under a licensing agreement with Novocell.
Human Embryonic Stem Cells (HESC) Market, Key Players
· Astellas Institute of Regenerative Medicine
· Asterias Biotherapeutics Inc.
· BD Biosciences
· Cell Cure Neurosciences Ltd. (Israel)
· Cellular Dynamics International
· GE Healthcare (UK)
· MilliporeSigma
· PerkinElmer Inc.
· Reliance Life Sciences Ltd. (India)
· Research and Diagnostics Systems Inc.
· SABiosciences Corp.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Human Embryonic Stem Cells (HESC) Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Type
- 5.2.1. Totipotent Stem Cell
- 5.2.2. Pluripotent Stem Cell
- 5.2.3. Unipotent Stem Cell
- 5.3. Market Analysis, Insights and Forecast – By Application
- 5.3.1. Regenerative medicine
- 5.3.2. Stem cell biology research
- 5.3.3. Tissue engineering
- 5.3.4. Toxicology testing
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America, Middle East, and Africa
6. North America Human Embryonic Stem Cells (HESC) Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Type
- 6.2.1. Totipotent Stem Cell
- 6.2.2. Pluripotent Stem Cell
- 6.2.3. Unipotent Stem Cell
- 6.3. Market Analysis, Insights and Forecast – By Application
- 6.3.1. Regenerative medicine
- 6.3.2. Stem cell biology research
- 6.3.3. Tissue engineering
- 6.3.4. Toxicology testing
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Human Embryonic Stem Cells (HESC) Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Type
- 7.2.1. Totipotent Stem Cell
- 7.2.2. Pluripotent Stem Cell
- 7.2.3. Unipotent Stem Cell
- 7.3. Market Analysis, Insights and Forecast – By Application
- 7.3.1. Regenerative medicine
- 7.3.2. Stem cell biology research
- 7.3.3. Tissue engineering
- 7.3.4. Toxicology testing
- 7.4. Market Analysis, Insights and Forecast – By Country
- 7.4.1. UK
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Russia
- 7.4.7. Rest of Europe
8. Asia Pacific Human Embryonic Stem Cells (HESC) Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Type
- 8.2.1. Totipotent Stem Cell
- 8.2.2. Pluripotent Stem Cell
- 8.2.3. Unipotent Stem Cell
- 8.3. Market Analysis, Insights and Forecast – By Application
- 8.3.1. Regenerative medicine
- 8.3.2. Stem cell biology research
- 8.3.3. Tissue engineering
- 8.3.4. Toxicology testing
- 8.4. Market Analysis, Insights and Forecast – By Country
- 8.4.1. China
- 8.4.2. India
- 8.4.3. Japan
- 8.4.4. Australia
- 8.4.5. South East Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America, Middle East, and Africa Human Embryonic Stem Cells (HESC) Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Type
- 9.2.1. Totipotent Stem Cell
- 9.2.2. Pluripotent Stem Cell
- 9.2.3. Unipotent Stem Cell
- 9.3. Market Analysis, Insights and Forecast – By Application
- 9.3.1. Regenerative medicine
- 9.3.2. Stem cell biology research
- 9.3.3. Tissue engineering
- 9.3.4. Toxicology testing
- 9.4. Market Analysis, Insights and Forecast – By Country
- 9.4.1. Brazil
- 9.4.2. Saudi Arabia
- 9.4.3. UAE
- 9.4.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. SABiosciences Corp.
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Astellas Institute of Regenerative Medicine
- 10.6. Asterias Biotherapeutics Inc.
- 10.7. BD Biosciences
- 10.8. Cell Cure Neurosciences Ltd. (Israel)
- 10.9. Cellular Dynamics International
- 10.10. GE Healthcare (UK)
- 10.11. MilliporeSigma
- 10.12. PerkinElmer Inc.
- 10.13. Reliance Life Sciences Ltd. (India)
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
